290 related articles for article (PubMed ID: 34060591)
1. The parkinsonism-associated protein FBXO7 cooperates with the BAG6 complex in proteasome function and controls the subcellular localization of the complex.
Wang Q; Crnković V; Preisinger C; Stegmüller J
Biochem J; 2021 Jun; 478(12):2179-2199. PubMed ID: 34060591
[TBL] [Abstract][Full Text] [Related]
2. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.
Vingill S; Brockelt D; Lancelin C; Tatenhorst L; Dontcheva G; Preisinger C; Schwedhelm-Domeyer N; Joseph S; Mitkovski M; Goebbels S; Nave KA; Schulz JB; Marquardt T; Lingor P; Stegmüller J
EMBO J; 2016 Sep; 35(18):2008-25. PubMed ID: 27497298
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
[TBL] [Abstract][Full Text] [Related]
4. Nuclear BAG6-UBL4A-GET4 complex mediates DNA damage signaling and cell death.
Krenciute G; Liu S; Yucer N; Shi Y; Ortiz P; Liu Q; Kim BJ; Odejimi AO; Leng M; Qin J; Wang Y
J Biol Chem; 2013 Jul; 288(28):20547-57. PubMed ID: 23723067
[TBL] [Abstract][Full Text] [Related]
5. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).
Kang J; Chung KC
Cell Mol Life Sci; 2015 Jan; 72(1):181-95. PubMed ID: 24947323
[TBL] [Abstract][Full Text] [Related]
6. Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
Teixeira FR; Randle SJ; Patel SP; Mevissen TE; Zenkeviciute G; Koide T; Komander D; Laman H
Biochem J; 2016 Oct; 473(20):3563-3580. PubMed ID: 27503909
[TBL] [Abstract][Full Text] [Related]
7. Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins.
Nelson DE; Randle SJ; Laman H
Open Biol; 2013 Oct; 3(10):130131. PubMed ID: 24107298
[TBL] [Abstract][Full Text] [Related]
8. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
[TBL] [Abstract][Full Text] [Related]
9. Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor.
Kirk R; Laman H; Knowles PP; Murray-Rust J; Lomonosov M; Meziane el K; McDonald NQ
J Biol Chem; 2008 Aug; 283(32):22325-35. PubMed ID: 18495667
[TBL] [Abstract][Full Text] [Related]
10. E3 ligase adaptor FBXO7 contributes to ubiquitination and proteasomal degradation of SIRT7 and promotes cell death in response to hydrogen peroxide.
Lee SH; Lee YJ; Jung S; Chung KC
J Biol Chem; 2023 Mar; 299(3):102909. PubMed ID: 36646384
[TBL] [Abstract][Full Text] [Related]
11. Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.
Joseph S; Vingill S; Jahn O; Fledrich R; Werner HB; Katona I; Möbius W; Mitkovski M; Huang Y; Weis J; Sereda MW; Schulz JB; Nave KA; Stegmüller J
J Neurosci; 2019 Jul; 39(28):5606-5626. PubMed ID: 31085610
[TBL] [Abstract][Full Text] [Related]
12. Structure and Function of Fbxo7/PARK15 in Parkinson's Disease.
Randle SJ; Laman H
Curr Protein Pept Sci; 2017; 18(7):715-724. PubMed ID: 26965690
[TBL] [Abstract][Full Text] [Related]
13. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
[TBL] [Abstract][Full Text] [Related]
14. Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect.
Correa-Vela M; Lupo V; Montpeyó M; Sancho P; Marcé-Grau A; Hernández-Vara J; Darling A; Jenkins A; Fernández-Rodríguez S; Tello C; Ramírez-Jiménez L; Pérez B; Sánchez-Montáñez Á; Macaya A; Sobrido MJ; Martinez-Vicente M; Pérez-Dueñas B; Espinós C
Ann Clin Transl Neurol; 2020 Aug; 7(8):1436-1442. PubMed ID: 32767480
[TBL] [Abstract][Full Text] [Related]
15. The characteristics of FBXO7 and its role in human diseases.
Zhong Y; Li J; Ye M; Jin X
Gene; 2023 Jan; 851():146972. PubMed ID: 36261086
[TBL] [Abstract][Full Text] [Related]
16. A ubiquitin-like domain recruits an oligomeric chaperone to a retrotranslocation complex in endoplasmic reticulum-associated degradation.
Xu Y; Liu Y; Lee JG; Ye Y
J Biol Chem; 2013 Jun; 288(25):18068-76. PubMed ID: 23665563
[TBL] [Abstract][Full Text] [Related]
17. FBXO7 triggers caspase 8-mediated proteolysis of the transcription factor FOXO4 and exacerbates neuronal cytotoxicity.
Lee SH; Jung S; Lee YJ; Hyun M; Chung KC
J Biol Chem; 2021 Dec; 297(6):101426. PubMed ID: 34800438
[TBL] [Abstract][Full Text] [Related]
18. Fbxo7 and Pink1 play a reciprocal role in regulating their protein levels.
Huang T; Fang L; He R; Weng H; Chen X; Ye Q; Qu D
Aging (Albany NY); 2020 Dec; 13(1):77-88. PubMed ID: 33291077
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Cullin7 E3 ubiquitin ligase--heterodimerization of cullin substrate receptors as a novel mechanism to regulate cullin E3 ligase activity.
Ponyeam W; Hagen T
Cell Signal; 2012 Jan; 24(1):290-5. PubMed ID: 21946088
[TBL] [Abstract][Full Text] [Related]
20. Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15).
Zhao T; De Graaff E; Breedveld GJ; Loda A; Severijnen LA; Wouters CH; Verheijen FW; Dekker MC; Montagna P; Willemsen R; Oostra BA; Bonifati V
PLoS One; 2011 Feb; 6(2):e16983. PubMed ID: 21347293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
